Thursday, November 14, 2019
Workshop A: Continuous Glucose Monitoring
Panel 1: Technical
8:00
Moderators
Naomi Schwartz, MS
United States Food and Drug Administration, Silver Spring, Maryland
Koji Sode, PhD
University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
8:05
Technology to Improve Performance
Peter Simpson, MS
Dexcom, San Diego, California
8:20
Technology to Improve Performance
Robert Mucic, PhD
Medtronic Diabetes, Northridge, California
8:35
Technology to Improve Performance
Yanan Zhang, PhD
Zhejiang POCTech Co., Ltd., Huzhou, China
8:50
A Novel Implanted Osmotic Glucose Sensor
Andreas Pfützner, MD, PhD
Pfützner Science and Health Institute, Mainz, Germany
9:05
Technology to Improve Performance
Alex Ghesquiere, BS
Senseonics, Germantown, Maryland
9:20
Q & A
9:35
Break
Panel 2: Interstitial Fluid
9:55
Moderators
Jeff Labelle, PhD
Grand Canyon University, Phoenix, Arizona
Dorian Liepmann, PhD
University of California, Berkeley, Berkeley, California
10:00
Interstitial Fluid Physiology
Sanjiv Sharma, PhD
Swansea University, Wales, United Kingdom
10:15
Limitations of Current Transdermal CGM Devices from a Tissue Perspective
Ulrike Klueh, PhD
Wayne State University, Detroit, Michigan
10:30
Sampling Interstitial Fluid from Skin Using a Microneedle Patch
Mark Prausnitz, PhD
Georgia Institute of Technology, Atlanta, Georgia
10:45
Harvesting and Assaying ISF Using Microneedles
Phillip Mach, PhD, MRSC
US Army, Aberdeen Proving Ground, Maryland
11:00
Q & A
11:30
End of Workshop/Lunch
Workshop B: Diabetic Complications: Success and Failure
Panel 1: Success with Foot Ulcers
8:00
Moderators
Robert Burk, MD
Albert Einstein College of Medicine, Bronx, New York
Jerry Sydorak, MD
Campus Sugery Center, Burlingame, California
8:05
NIH Programs for Diabetes Foot Wound Technology
Teresa Jones, PhD
National Institutes of Health, Bethesda, Maryland
8:20
Will Smart Technologies Make Our Treatment Smarter? The Promise and Barriers of Digital Health to Manage Diabetic Foot Complications
Bijan Najafi, PhD
Baylor College of Medicine, Houston, Texas
8:35
Smart Shoes and DFU Prevention
Josh White
Sensoria Health Inc., Redmond, Washington
8:50
Smart Mat Platform and Prevention of DFU
Jon Bloom, MD
Podimetrics, Cambridge, Massachusetts
9:05
Q & A
9:35
Break
Panel 2: Overcoming Barriers
9:55
Moderators
Stacey Anderson, MD, CDTC
University of Virginia, Charlottesville, Virginia
Ilias Spanakis, MD
University of Maryland, Baltimore, Maryland
10:00
Hypoglycemia Alarms
Bruce Buckingham, MD
Stanford University, Palo Alto, California
10:15
Insulin Pump Occlusions
Guido Freckmann, MD
Institute for Diabetes Technology GmBH, Ulm, Germany
10:30
Modeling CGM or AP Failure
Eyal Dassau, PhD
Harvard University, Cambridge, Massachusetts
10:45
Local Temperature Control of Insulin Absorption
Gabriel Bitton, PhD, MS
InsuLine Medical Ltd, Petah Tikva, Israel
11:00
Q & A
11:30
End of Workshop/Lunch
Workshop C: Digital Health
Panel 1: Insulin Dosing
12:30
Moderators
Rosemarie Oshinsky, RN, CDE
Sibley Memorial Hospital, Bethesda, Maryland
Kayo Waki, MD, PhD, MPH
University of Tokyo, Tokyo, Japan
12:35
Potential Benefits of Smart Insulin Pens
David Kerr, MD
Sansum Diabetes Research Institute, Santa Barbara, California
12:55
Insulin Pen Technology
Anders Toft, MD, PhD, eMBA
Novo Nordisk, Copenhagen, Denmark
13:15
Mobile Apps for Insulin Dosing
Jessica Castle, MD
Oregon Health Sciences University, Portland, Oregon
13:35
Insulin Dosing Metrics
Jennal Johnson, FNP, MS
Eli Lilly, Indianapolis, Indiana
13:55
Q & A
14:05
Break
Panel 2: Lifestyle
14:25
Moderators
David Kerr, MD
Sansum Diabetes Research Institute, Santa Barbara, California
Andrzej Kropwnicki, MA
Alfa Communications, Warsaw, Poland
14:30
Person-Centered Diabetes Technology: Why We Have to Do Better
Korey Hood, PhD
Stanford University, Palo Alto, California
14:45
Using Digital Health to Increase Adherence
Maureen Monaghan, PhD, CDE
Children's National Hospital, Washington, District of Columbia
15:00
The Benefits of Integrated Care
Chris Boulton, BSc
Sanofi, Bridgewater, New Jersey
15:15
Cybersecurity of Medical Devices
Aiman Abdel-Malek, PhD
ThirdwayV Inc., Irvine, California
15:30
Q & A
16:00
End of Workshop
16:30
Poster Session Night One, Startup Showcase, and Inauguration of the 19th Annual Diabetes Technology Meeting
18:30
Posters Remain on Display for Viewing
Workshop D: Blood Glucose Monitoring: What Is Its Future?
Panel 1: Glucose Data
12:30
Moderators
Mark Arnold, PhD
University of Iowa, Iowa City, Iowa
Anant Nigam, MD, FRCP
Nigam Diabetes Center, Jaipur, India
12:35
Strategies to Enhance the Value of Glucose Data: Integrating - Sharing - Expanding Access
Rolf Hinzmann, MD, PhD
Roche Diagnostics, Mannheim, Germany
12:50
The Need for a Standard for Color-Coded Blood Glucose Values
Larry Katz, PhD
LifeScan, Wayne, Pennsylvania
13:05
Glycemic Variability Metrics: Comparison of SMBG and CGM
David Rodbard, MD
Biomedical Informatics Consultants LLC, Potomac, Maryland
13:20
Glucose Meter Adverse Events
Jan Krouwer, PhD
Krouwer Consulting, Sherborn, Massachusetts
13:35
Q & A
14:05
Break
Panel 2: The Future
14:25
Moderators
Kong Chen, PhD
NIDDK/NIH, Bethesda, Maryland
Robert Gabbay, MD, PhD
Joslin Diabetes Center, Boston, Massachusetts
14:30
Debate: Does SMBG Have a Future?
Nick Argento, MD, FACE
Maryland Endocrine and Diabetes, Columbia, Maryland
Timothy Bailey, MD, FACE, FACP, CPI
AMCR Institute, Escondido, California
15:20
New Technology for BGM
Andreas Pfützner, MD, PhD
Pfützner Science and Health Institute, Mainz, Germany
15:35
What Do We Want from the Future?
John Pickup, MA, BM, DPhil, DSc, FRCPath
King's College London, London, United Kingdom
15:50
Importance of Cybersecurity for BGMs
Robert Hurtz, MS
Ascensia Diabetes Care, Tarrytown, New York
16:05
Q & A
16:25
End of Workshop
16:30
Poster Session Night One, Startup Showcase, and Inauguration of the 19th Annual Diabetes Technology Meeting
18:30
Posters Remain on Display for Viewing
Friday, November 15, 2019
7:00
Continental Breakfast
Session 1: Biosensing and Diabetes Data Science
8:00
Welcome/Opening Remarks
David Klonoff, MD, FACP, FRCP (Edin), Fellow AIMBE
Mills-Peninsula Medical Center, San Mateo, California
UCSF, San Francisco, California
8:05
KEYNOTE: Research Opportunities for Diabetes Using Bioengineered Tools
Bruce Tromberg, PhD
Director, National Institute of Biomedical Imaging and Bioengineering, Bethesda, Maryland
8:30
Moderators
Wayne Bequette, PhD
Rensselaer Polytechnic Institute, Troy, New York
Robert Gabbay, MD, PhD
Joslin Diabetes Center, Boston, Massachusetts
8:35
Optimizing Glycemic Outcomes Through New Biosensors, Machine Learning, and Adaptive Control
Peter Jacobs, PhD
Oregon Health and Science University, Portland, Oregon
8:50
Accelerating Product Innovation via Simulation
Stephen Patek, PhD
Dexcom, Charlottesville, Virginia
9:05
Using Big Data for Diabetes Technology Research
Ashutosh Sabharwal, PhD
Rice University, Houston, Texas
9:20
Q & A
9:40
Break
Session 2: Regulation of Diabetes Technology
10:05
Moderators
Zan Fleming, MD
Kinexum, Harpers Ferry, West Virginia
Alberto Gutierrez, PhD
NDA Partners, LLC, Bethesda, Maryland
10:10
MAUDE Database
Alain Silk, PhD
United States Food and Drug Administration, Silver Spring, Maryland
10:20
Real World Evidence for Clinical Trials
Yiduo Wu, PhD
United States Food and Drug Administration, Silver Spring, Maryland
10:30
Interoperable Devices – iCGM and ACE Designation
Joshua Balsam, PhD
United States Food and Drug Administration, Silver Spring, Maryland
10:40
Cybersecurity
Naomi Schwartz, MS
United States Food and Drug Administration, Silver Spring, Maryland
10:50
SaMd/ Precertification Program
Bakul Patel, MSEE, MBA
United States Food and Drug Administration, Silver Spring, Maryland
11:00
Navigating the FDA Process
Yarmela Pavlovic, JD
Hogan Lovells, San Francisco, California
11:10
Q & A
11:35
End of Session/Lunch
Session 3: CGM Data Analysis
12:35
DTS Leadership Award
12:40
Moderators
Will Cefalu, MD
NIDDK/NIH, Bethesda, Maryland
John Melish, MD
University of Hawaii, Kailua, Hawaii
12:45
Time in Range: A Critical Appraisal
Lutz Heinemann, PhD
Science & Co., Düsseldorf, Germany
13:00
The Importance of Time-In-Range in Assessing Glycemic Control
Richard Bergenstal, MD
International Diabetes Center, Minneapolis, Minnesota
13:15
CGM Data Structure and Analysis of Time-In-Range and Other Metrics of Glycemic Control
Boris Kovatchev, PhD
University of Virginia, Charlottesville, Virginia
13:30
FDA Perspective on CGM-Based Biomarkers
Courtney Lias, PhD
United States Food and Drug Administration, Silver Spring, Maryland
13:40
Q & A
Session 4: Artificial Pancreas
13:45
Moderators
Guillermo Arreaza-Rubin, MD
NIDDK/NIH, Bethesda, Maryland
Jeffrey Joseph, DO
Thomas Jefferson University, Philadelphia, Pennsylvania
13:50
Artificial Pancreas Award
13:55
An Overview of Recent Studies
Boris Kovatchev, PhD
University of Virginia, Charlottesville, Virginia
14:05
Project Nightlight
Sue Brown, MD
University of Virginia, Charlottesville, Virginia
14:15
CamApS FX – Taking Forward Cambridge Artificial Pancreas Experience
Roman Hovorka, PhD
University of Cambridge, Cambridge, United Kingdom
14:25
Advances in Closed Loop Therapies
Patrick Weydt, MBA
Medtronic Diabetes, Northridge, California
14:35
Closed Loop Without a Meal Announcement
Ali Cinar, PhD
Illinois Institute of Technology, Chicago, Illinois
14:45
Did We Get What We Ordered? Insulin, Infusion Lines, Modeling and Control
Geoff Chase, PhD
University of Canterbury, Christchurch, New Zealand
14:55
Q & A
15:10
End of Session/Break
Session 5: How to Increase Use of CGM
15:35
Moderators
Sammy Choi, MD
Womack Army Medical Center, Fort Bragg, North Carolina
Ronnie Goodstein, PhD
Georgetown University, Washington, District of Columbia
15:40
How to Increase Use of CGM
Roy Beck, MD, PhD
JAEB Center for Health Research, Tampa, Florida
Bruce Buckingham, MD
Stanford University, Palo Alto, California
Francine Kaufman, MD
Senseonics, Germantown, Maryland
David Price, MD
Dexcom, San Diego, California
Andreas Stuhr, MD, MBA
Ascensia Diabetes Care, Parsippany, New Jersey
Robert Vigersky, MD
Medtronic Diabetes, Washington, District of Columbia
16:15
Q & A
16:25
End of Session
16:30
Poster Session Night Two and Startup Showcase
18:30
Posters Remain on Display for Viewing
Saturday, November 16, 2019
7:00
Continental Breakfast
Session 6: Novel Insulins
8:00
Moderators
Gerold Grodsky, PhD
UCSF, San Francisco, California
Nestoras Mathioudakis, MD
Johns Hopkins University, Baltimore, Maryland
8:05
Welcome/Recap of First Day and Presentation of Student Award
David Klonoff, MD, FACP, FRCP (Edin), Fellow AIMBE
Mills-Peninsula Medical Center, San Mateo, California
UCSF, San Francisco, California
8:10
Gold Prize Student Presentation: A Comparison of Macronutrient and Energy Content Estimates by GoFOOD™ vs Dietitians: A Preliminary Analysis
Maria Vasiloglou, MSc
University of Bern, Bern, Switzerland
8:25
Novel Glucagon Formulations
Jessica Castle, MD
Oregon Health Sciences University, Portland, Oregon
8:45
Future Insulins: Gazing Into a Crystal Ball
Tim Heise, MD
Profil, Neuss, Germany
9:05
An Ultra-Stable Single Chain Insulin Analog
Michael Weiss, MD
Case Western University, Cleveland, Ohio
9:25
Hepatic Directed Insulin
Doug Muchmore, MD
Diasome, Cleveland, Ohio
9:45
Q & A
10:05
Break
Session 7: Novel Insulin Delivery Technology
10:25
Moderators
Andrew Bremer, MD, PhD
NICHD/NIH, Bethesda, Maryland
Julia Mader, MD, PhD
Medical University of Graz, Graz, Austria
10:30
Technologies for Improved Insulin Delivery Are Necessary, But Are They Sufficient?
David Harlan, MD
University of Massachusetts, Worcester, Massachusetts
10:45
Smart Insulin
Sanjoy Dutta, PhD
JDRF, New York, New York
11:00
An Insulin Pill That Delivers: Micro-Injections in the Gut
Alex Abramson, PhD
Stanford University, Palo Alto, California
11:15
Inhaled Insulin
David Kendall, MD
Mannkind Corporation, Thousand Oaks, California
11:30
Critical Factors for Insulin Delivery: Towards an Understanding of Uptake Variability
Ron Pettis, PhD
BD, Research Triangle Park, New Jersey
11:45
Q & A
12:00
End of Session/Lunch
Session 8: Disposal of Waste from Diabetes Products
13:00
Moderators
Hubert Vesper, PhD
Centers for Disease Control and Prevention, Atlanta, Georgia
Alicia Warnock, MD
Stability Health, Worcester, Massachusetts
13:05
Waste and Diabetes Technology: A Call for Action
Lutz Heinemann, PhD
Science & Co., Düsseldorf, Germany
13:20
Global Burden of Diabetes – From an Environmental Perspective
Ed Krisiunas, MPH
WNWN International, Burlington, Connecticut
13:35
Challenges for a Manufacturer to Reduce Waste Production
Tobias Stumpe, BS
Convatec, Copenhagen, Denmark
13:50
Q & A
Session 9: Hot Topics
14:05
Moderators
Thanh Hoang, DO
Walter Reed National Military Medical Center, Bethesda, Maryland
Victor Schneider, MD
NASA Headquarters, Washington, District of Columbia
14:10
Environmental Causes of Diabetes
Sultan Ayoub Meo, MD, PhD, FRCP
King Saud University, Riyadh, Saudi Arabia
14:25
Hypoglycemia Reduction as an End Point for Trials of Diabetes Products
Alexander Fleming, MD
Kinexum Services LLC, Harpers Ferry, West Virginia
14:40
A New Mathematical Link Between A1C and Blood Glucose
Yongjin Xu, PhD
Abbott Diabetes Care, Alameda, California
14:55
Q & A
15:10
Break
Session 10: Do It Yourself
15:35
Moderators
Carol Levy, MD, CDE
Icahn School of Medicine at Mount Sinai, New York, New York
John Pickup, MA, BM, DPhil, DSc, FRCPath
King's College London, London, United Kingdom
15:40
Factors Affecting Support of DIY Systems in Routine Clinical Care
Katharine Barnard, PhD
Bournemouth University, Hampshire, United Kingdom
15:55
The Bleeding Edge: Open Source Algorithms, Research, and What's Next
Dana Lewis, BA
OpenAPS, Seattle, Washington
16:10
Q & A
Session 11: Live Demonstrations
16:20
Moderator
John Pickup, MA, BM, DPhil, DSc, FRCPath
King's College London, London, United Kingdom
16:25
Glooko – The Standard for Diabetes Data Management
Dave Conn, BA
Glooko, Inc., Mountain View, California
Mark Clements, MD, PhD
Glooko, Inc., Mountain View, California
16:40
Duodenal Mucosa Resurfacing for the Treatment of Type 2 Diabetes
Juan Carlos Lopez-Talavera, MD, PhD
Fractyl Laboratories, Inc., Lexington, Massachusetts
17:00
Adjourn